A Study of BBI503 in Combination With Selected Anti-Cancer Therapeutics in Adult Patients With Advanced Cancer
Clinical trial NCT02483247 · COMPLETED
Trial details
- NCT number
- NCT02483247
- Sponsor
- Sumitomo Pharma America, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-09-01
- Primary completion
- 2019-05-01
- Enrollment
- 165
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.